Notice Number: NOT-TR-20-020
Release Date: April 8, 2020
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to inform prospective applicants that, effective immediately, the National Center for Advancing Translational Sciences (NCATS) is no longer participating in PAR-18-691 “Innovative Therapies and Tools for Screenable Disorders in Newborns (R21 Clinical Trial Optional)”. NCATS will no longer accept applications submitted to this Funding Opportunity Announcement.
Please direct all inquiries to:
NCATS Referral Office